The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease

Abstract excerpt

Sickle cell disease (SCD) is a chronic disease affecting people across their lifespans.Individuals with SCD face life-threatening complications, including vaso-occlusive pain episodes and chronic end-organ damage.Although SCD affects about 110 000 Americans, health care costs for this population are about $3 billion per year or $30 000 per person. 1,2

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood groups and transfusion
• Share to Hemoglobinopathies and Related Disorders
• Share to Iron Metabolism and Disorders